Endometrial cancer

Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. http://seer.cancer.gov/faststats. [accessed on 12.12.2011].

Tran, 2000, Characteristics and outcome of endometrial carcinoma patients age 45 years and younger, Am J Clin Oncol, 23, 476, 10.1097/00000421-200010000-00009

Soliman, 2005, Risk factors for young premenopausal women with endometrial cancer, Obstet Gynecol, 105, 575, 10.1097/01.AOG.0000154151.14516.f7

Schmeler, 2008, Gynecologic cancers associated with Lynch syndrome/HNPCC, Clin Transl Oncol, 10, 313, 10.1007/s12094-008-0206-9

Shah, 2011, Management of endometrial cancer in young women, Clin Obstet Gynecol, 54, 219, 10.1097/GRF.0b013e318218607c

Frumovitz, 2006, Fertility-sparing therapy for young women with endometrial cancer, Expert Rev Anticancer Ther, 6, 27, 10.1586/14737140.6.1.27

Navarria, 2009, Young patients with endometrial cancer: How many could be eligible for fertility-sparing treatment?, Gynecol Oncol, 114, 448, 10.1016/j.ygyno.2009.05.038

Yamazawa, 2007, Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer, Hum Reprod, 22, 1953, 10.1093/humrep/dem088

Shamshirsaz, 2007, Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review, Gynecol Oncol, 104, 757, 10.1016/j.ygyno.2006.11.013

Walsh, 2005, Coexisting ovarian malignancy in young women with endometrial cancer, Obstet Gynecol, 106, 693, 10.1097/01.AOG.0000172423.64995.6f

Zaino, 2001, Simultaneously detected endometrial and ovarian carcinomas: a prospective clinicopathologic study of 74 cases: a Gynecologic Oncology Group Study, Gynecol Oncol, 83, 355, 10.1006/gyno.2001.6400

Creasman, 1987, Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study, Cancer, 60, 2035, 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8

Chi, 2008, The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology, Int J Gynecol Cancer, 18, 269, 10.1111/j.1525-1438.2007.00996.x

Yamazawa, 2000, Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature, Int J Gynecol Cancer, 10, 212, 10.1046/j.1525-1438.2000.010003212.x

Yasumizu, 1996, Comparison of the clinicopathological characteristics of premenopausal and postmenopausal endometrial carcinomas: analysis of endocrinologically evaluated cases, Jpn J Clin Oncol, 26, 152, 10.1093/oxfordjournals.jjco.a023199

Lee, 2007, Prognostic factors for uterine cancer in reproductive-aged women, Obstet Gynecol, 109, 655, 10.1097/01.AOG.0000255980.88205.15

Jacques, 1998, Interinstitutional surgical pathology review in gynecologic oncology: I. Cancer in endometrial curettings and biopsies, Int J Gynecol Pathol, 17, 36, 10.1097/00004347-199801000-00007

Jacques, 1998, Interinstitutional surgical pathology review in gynecologic oncology: II. Endometrial cancer in hysterectomy specimens, Int J Gynecol Pathol, 17, 42, 10.1097/00004347-199801000-00008

Yang, 2011, Progesterone: the ultimate endometrial tumor suppressor, Trends Endocrinol Metabol, 22, 145, 10.1016/j.tem.2011.01.005

Lai, 2006, The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer, Curr Opin Obstet Gynecol, 18, 29, 10.1097/01.gco.0000192994.37965.c6

Mazzon, 2010, Conservative surgical management of stage IA endometrial carcinoma for fertility preservation, Fertil Steril, 93, 1286, 10.1016/j.fertnstert.2008.12.009

Song, 2011, Prognostic significance of DNA ploidy in stage I endometrial cancer, Gynecol Oncol, 122, 79, 10.1016/j.ygyno.2011.03.017

Gadducci, 2009, The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option, Gynecol Endocrinol, 25, 683, 10.1080/09513590902733733

Savelli, 2008, Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging, Ultrasound Obstet Gynecol, 31, 560, 10.1002/uog.5295

Zerbe, 2000, Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer, Gynecol Oncol, 78, 67, 10.1006/gyno.2000.5820

Sala, 2010, The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis, Eur J Radiol, 76, 367, 10.1016/j.ejrad.2010.01.026

Cade, 2010, Predictive value of magnetic resonance imaging in assessing myometrial invasion in endometrial cancer, Int J Gynecol Cancer, 20, 1166, 10.1111/IGC.0b013e3181e9509f

Sala, 2009, Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma, Int J Gynecol Cancer, 19, 141, 10.1111/IGC.0b013e3181995fd9

Vasconcelos, 2007, Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation, J Obstet Gynaecol, 27, 65, 10.1080/01443610601056418

Rasool, 2010, Fertility-preserving surgical procedures for patients with gynecologic malignancies, Clin Obstet Gynecol, 53, 804, 10.1097/GRF.0b013e3181f97d02

Rockall, 2005, Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer, J Clin Oncol, 23, 2813, 10.1200/JCO.2005.07.166

Horowitz, 2004, Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer, Gynecol Oncol, 95, 546, 10.1016/j.ygyno.2004.08.009

Inubashiri, 2009, Positron emission tomography with the glucose analog [18F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: Comparison with CT and MRI findings, J Obstet Gynaecol Res, 35, 26, 10.1111/j.1447-0756.2008.00832.x

Saegusa, 1998, Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis, Cancer, 83, 111, 10.1002/(SICI)1097-0142(19980701)83:1<111::AID-CNCR15>3.0.CO;2-#

Randall, 1997, Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40, Obstet Gynecol, 90, 434, 10.1016/S0029-7844(97)00297-4

Hahn, 2009, Conservative Treatment With Progestin and Pregnancy Outcomes in Endometrial Cancer, Int J Gynecol Cancer, 19, 1068, 10.1111/IGC.0b013e3181aae1fb

Cade, 2010, Progestogen treatment options for early endometrial cancer, BJOG, 117, 879, 10.1111/j.1471-0528.2010.02552.x

Ushijima, 2007, Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women, J Clin Oncol, 25, 2798, 10.1200/JCO.2006.08.8344

Montz, 2002, Intrauterine progesterone treatment of early endometrial cancer, Am J Obstet Gynecol, 186, 651, 10.1067/mob.2002.122130

Wheeler, 2007, Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins, Am J Surg Pathol, 31, 988, 10.1097/PAS.0b013e31802d68ce

Erkanli, 2010, Fertility-sparing therapy in young women with endometrial cancer, Int J Gynecol Cancer, 20, 1170, 10.1111/IGC.0b013e3181e94f5a

Cade, 2010, Progestogen treatment options for endometrial cancer, BJOG, 117, 879, 10.1111/j.1471-0528.2010.02552.x

Suh-Burgmann, 2009, Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage, Obstet Gynecol, 114, 523, 10.1097/AOG.0b013e3181b190d5

Sparac, 2006, Successful pregnancy after hysteroscopic removal of grade I endometrial carcinoma in a young woman with Lynch syndrome, Int J Gynecol Cancer, 16, 442, 10.1111/j.1525-1438.2006.00219.x

Boks, 2002, Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer, Int J Cancer, 102, 198, 10.1002/ijc.10667

Tangjitgamol, 2009, Fertility-Sparing in Endometrial Cancer, Gynecol Obstet Invest, 67, 250, 10.1159/000209324